Basit öğe kaydını göster

dc.contributor.authorAlkan, Faruk
dc.contributor.authorIsler, Cihan
dc.contributor.authorEser, Mediha
dc.contributor.authorErdincler, Pamir
dc.contributor.authorTanriverdi, Taner
dc.contributor.authorASAN, ZİYA
dc.date.accessioned2021-03-05T07:26:55Z
dc.date.available2021-03-05T07:26:55Z
dc.date.issued2019
dc.identifier.citationASAN Z., Eser M., Tanriverdi T., Isler C., Alkan F., Erdincler P., "Comparison of the effects of levetiracetam and valproic acid on neural tube defect formation in the chick embryo: an experimental study", ANNALS OF CLINICAL AND ANALYTICAL MEDICINE, cilt.10, ss.453-457, 2019
dc.identifier.othervv_1032021
dc.identifier.otherav_93d50187-7987-4f4b-af47-5a3a42aedfe1
dc.identifier.urihttp://hdl.handle.net/20.500.12627/99605
dc.identifier.urihttps://doi.org/10.4328/acam.5964
dc.description.abstractAim: The aim of this study is to compare the dosage-related effects of levetiracetam and valproic acid on neural tube defect formation in chick embryos, when applied as monotherapy and in combination. Material and Method: A total of 360 fertilized pathogens-free white-Leghorn eggs were used in the study. The eggs were allowed to incubate for 72 hours. Total of six groups were formed where each medication was administered in low (250 mcg) and high (500 mcg) doses and in combination. Results obtained from the control and sham groups were compared. Results: The prevalence of NTD was found to be significantly lower in the group that received levetiracetam compared to the group that was treated with valproic acid. It was determined that NTD prevalence increased with a dosage increase in both groups. The prevalence of NTD was found to be significantly higher in groups where the two medications were administered in combination compared to the groups that received a single medication. Discussion: Both levetiracetam and valproic acid have the potential to create NTD. Valproic acid has a higher potential of creating NTD compared to levetiracetam. The likeliness of causing NTD significantly increases depending on dosage for both medications. Both medications have the potential to create NTD during pregnancy and must be used with caution.
dc.language.isoeng
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectTemel Tıp Bilimleri
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectTIP, GENEL & İÇECEK
dc.titleComparison of the effects of levetiracetam and valproic acid on neural tube defect formation in the chick embryo: an experimental study
dc.typeMakale
dc.relation.journalANNALS OF CLINICAL AND ANALYTICAL MEDICINE
dc.contributor.departmentKırşehir Ahi Evran Üniversitesi , Tıp Fakültesi , Beyin Ve Sinir Cerrahisi Anabilim Dalı
dc.identifier.volume10
dc.identifier.issue4
dc.identifier.startpage453
dc.identifier.endpage457
dc.contributor.firstauthorID265765


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster